RMC Pharmaceutical Solutions (RMC) was acquired by Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, in January of 2023. The combined team offers an impressive range of process and analytical development services, regulatory strategy, regulatory submission support, and quality management services. The acquisition also provides RMC biotech and pharma clients access to a full range of integrated development and regulatory services. Syner-G and RMC have strong records of consistent growth and success in providing customized solutions to support the development of life-enhancing and lifesaving therapeutics. The combination enhances their ability to deliver the highest caliber CMC services to pharma and biotech companies of all sizes on a global basis.
